Premium
A methodological framework of preparing economic evidence for selection of medicines in the Chinese setting
Author(s) -
Sun Xin,
Faunce Thomas Alured
Publication year - 2010
Publication title -
journal of evidence‐based medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 22
ISSN - 1756-5391
DOI - 10.1111/j.1756-5391.2010.01087.x
Subject(s) - guideline , context (archaeology) , selection (genetic algorithm) , china , component (thermodynamics) , economic evaluation , economic cost , public economics , business , risk analysis (engineering) , medicine , economics , computer science , political science , geography , physics , neoclassical economics , archaeology , pathology , artificial intelligence , law , thermodynamics
Medicines are becoming a major component of health expenditure in China. Selection of effective and cost‐effective medicines represents an important effort to improve medicines use. A guideline on cost‐effectiveness studies has been available in China. This guideline, however, fails to be a practical tool to prepare and critically appraise economic evidence. This article discusses, in the Chinese context, the approach to integrating economic component into the medicines selection, and elaborates the methods of producing economic evidence, including conducing economic reviews and primary economic studies.